Literature DB >> 9486938

Cardiac beta-adrenergic signaling pathway alteration in isoproterenol-induced cardiac hypertrophy in male Sprague-Dawley rats.

N Hakamata1, H Hamada, F Ohsuzu, H Nakamura.   

Abstract

Isoproterenol was continuously administered to rats at a rate of 2.5 microg/kg/min for 7 days via subcutaneously implanted osmotic minipumps. This treatment induced cardiac hypertrophy with increases in heart rate and systolic blood pressure. Beta-adrenoceptor (beta-AR) density decreased in hypertrophied hearts, but the affinity for 125I-cyanopindolol did not change. The beta-AR density decrease did not accompany the change in expression of beta1-AR mRNA. In hypertrophied hearts, adenylyl cyclase activities in the steady state, and stimulated with isoproterenol, forskolin, and manganese, decreased but there was no change in the expression of adenylyl cyclase type V mRNA. The results suggest that beta-AR downregulation and adenylyl cyclase desensitization in isoproterenol-induced cardiac hypertrophy are caused by post-transcriptional changes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9486938     DOI: 10.1536/ihj.38.849

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  3 in total

Review 1.  Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.

Authors:  Oleg E Osadchii
Journal:  Heart Fail Rev       Date:  2007-03-27       Impact factor: 4.654

2.  miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targetting c-Jun.

Authors:  Su Ming; Wang Shui-Yun; Qiu Wei; Li Jian-Hui; Hui Ru-Tai; Song Lei; Jia Mei; Wang Hui; Wang Ji-Zheng
Journal:  Biosci Rep       Date:  2018-03-09       Impact factor: 3.840

3.  CD47 Deficiency Attenuates Isoproterenol-Induced Cardiac Remodeling in Mice.

Authors:  Zhi Zuo; Ming-Yue Ji; Kun Zhao; Zhong-Ping Su; Peng Li; Dao-Rong Hou; Yong Li
Journal:  Oxid Med Cell Longev       Date:  2019-11-19       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.